Cover Image

Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives

Saved in:

Bibliographic Details
Main Authors:	Hao Sun (Author), Yingmei Li (Author), Peng Zhang (Author), Haizhou Xing (Author), Song Zhao (Author), Yongping Song (Author), Dingming Wan (Author), Jifeng Yu (Author)
Format:	Book
Published:	BMC, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
by: Hao Sun, et al.
Published: (2022)

Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
by: Weijie Cao, et al.
Published: (2022)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
by: Lingling Huang, et al.
Published: (2022)

Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea
by: Mostafa Abou El-Ela, et al.
Published: (2017)

Targeting TIGIT for cancer immunotherapy: recent advances and future directions
by: Peng Zhang, et al.
Published: (2024)

The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
by: Xue Chen, et al.
Published: (2022)

Toll-like Receptors
Published: (2020)

Toll-Like Receptors
by: Aycan Kundakcı, et al.
Published: (2012)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
by: Huju Chi, et al.
Published: (2017)

Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
by: Amani E. Khalifa, PhD, et al.
Published: (2021)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
by: Jing-Xing Yang, et al.
Published: (2022)

Candida and Toll-Like Receptors
by: Şayeste Demirezen, et al.
Published: (2012)

Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists
by: Sehwan Jeong, et al.
Published: (2021)

Is it possible to use the Toll-like receptors as biomarkers for neonatal sepsis? Review of the recent literature
by: Irina Melinda Baizat, et al.
Published: (2022)

Toll-Like Receptors and Myocardial Inflammation
by: Yan Feng, et al.
Published: (2011)

Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
by: Brueseke TJ, et al.
Published: (2013)

Inhibition of Toll-Like Receptor 2-Mediated Interleukin-8 Production in Cystic Fibrosis Airway Epithelial Cells via the α7-Nicotinic Acetylcholine Receptor
by: Catherine M. Greene, et al.
Published: (2010)

Spinal toll like receptor 3 is involved in chronic pancreatitis-induced mechanical allodynia of rat
by: Feng Quan-Xing, et al.
Published: (2011)

The role of Toll-like receptors in skin diseases
by: Joanna Bacharewicz, et al.
Published: (2014)

Toll-like receptors in dermatology, venereology, and leprosy
by: Sneha Gandhi, et al.
Published: (2021)

Neonatal innate immunity and Toll-like receptor
by: Hye Sun Yoon
Published: (2010)

Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases
by: Akbar Mohammad Hosseini, et al.
Published: (2015)

Targeting Toll-Like Receptors for Treatment of SLE
by: Christopher G. Horton, et al.
Published: (2010)

Toll-Like Receptors: Role in Dermatological Disease
by: Aswin Hari, et al.
Published: (2010)

The Expression and Functions of Toll-Like Receptors in Atherosclerosis
by: Jennifer E. Cole, et al.
Published: (2010)

Toll-Like Receptors, Tissue Injury, and Tumourigenesis
by: Savvas Ioannou, et al.
Published: (2010)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
by: Zhi-Mei Liu, et al.
Published: (2022)

Silymarin inhibits Toll-like receptor 8 gene expression and apoptosis in Ramos cancer cell line
by: Nasrin Ranjbar, et al.
Published: (2020)

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
by: Andreas Port, et al.
Published: (2021)

The Role of Toll-Like Receptors (TLR) in Infection and Inflammation
Published: (2023)

Toll-Like Receptor Activation in Immunity vs. Tolerance
by: Christophe M. Filippi
Published: (2015)

Toll-Like Receptors and Dental Mesenchymal Stromal Cells
by: Oleh Andrukhov
Published: (2021)

Toll-like receptor agonists as cancer vaccine adjuvants
by: Donghwan Jeon, et al.
Published: (2024)

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
by: Xiaohong Cen, et al.
Published: (2018)

Toll-Like Receptor 4 Signaling and Drug Addiction
by: Ruyan Wu, et al.
Published: (2020)

TIRAP, TRAM, and Toll-Like Receptors: The Untold Story
by: Valérie Lannoy, et al.
Published: (2023)

Toll-Like Receptor Signaling Pathways-Therapeutic Opportunities
by: Jiankun Zhu, et al.
Published: (2010)

Classification, Mechanisms of Action, and Therapeutic Applications of Inhibitory Oligonucleotides for Toll-Like Receptors (TLR) 7 and 9
by: Petar S. Lenert
Published: (2010)

Reduction of voluntary physical activity in mice induced by toll-like receptor 7 agonist R-848
by: Eri Oyanagi, et al.
Published: (2018)

WITHDRAWN: SPOP Promotes Acute Myeloid Leukemia Initiation and Development Through miR-183-Mediated METAP2 Inhibition
by: Jifeng Yu, et al.
Published: (2024)